Understanding the Role of Perilipin 5 in Non-Alcoholic Fatty Liver Disease and Its Role in Hepatocellular Carcinoma: A Review of Novel Insights

Understanding the Role of Perilipin 5 in Non-Alcoholic Fatty Liver Disease and Its Role in Hepatocellular Carcinoma: A Review of Novel Insights

Consumption of high-calorie foods, such as diets rich in fats, is an important factor leading to the development of steatohepatitis. Several studies have suggested how lipid accumulation creates a lipotoxic microenvironment for cells, leading cells to deregulate their transcriptional and translation...

Full description

Bibliographic Details
Main Authors:	Paola Berenice Mass Sanchez, Marinela Krizanac, Ralf Weiskirchen, Anastasia Asimakopoulos
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	International Journal of Molecular Sciences
Subjects:	perilipin 5 non-alcoholic liver disease fatty liver hepatocellular carcinoma cancer
Online Access:	https://www.mdpi.com/1422-0067/22/10/5284

Similar Items

A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
by: Marinela Krizanac, et al.
Published: (2021-03-01)

The Effects of High-Intensity Interval Training on the Visceral Adipose Tissue Perilipin3 and Perilipin5 Genes Expression in Obese Male Rats with Non-Alcoholic Fatty Liver Disease
by: Nafiseh Sadeghi, et al.
Published: (2024-03-01)

Lipid-Independent Regulation of PLIN5 via IL-6 through the JAK/STAT3 Axis in Hep3B Cells
by: Marinela Krizanac, et al.
Published: (2023-04-01)

Involvement of Lipophagy and Chaperone-Mediated Autophagy in the Pathogenesis of Non-Alcoholic Fatty Liver Disease by Regulation of Lipid Droplets
by: Eleftheria M. Mastoridou, et al.
Published: (2023-11-01)

The Development of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease
by: Oh Sang Kwon, et al.
Published: (2017-06-01)

Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
by: Rahul Kumar, et al.
Published: (2020-04-01)

Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
by: Ju Hyun Shim
Published: (2020-04-01)

Imaging cytoplasmic lipid droplets in vivo with fluorescent perilipin 2 and perilipin 3 knock-in zebrafish
by: Meredith H Wilson, et al.
Published: (2021-08-01)

RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: Lourianne Nascimento CAVALCANTE, et al.
Published: (2022-11-01)

Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma
by: Ji-Qiao Zhu, et al.
Published: (2024-04-01)

Roles of N6‐methyladenosine epitranscriptome in non‐alcoholic fatty liver disease and hepatocellular carcinoma
by: Yuyan Chen, et al.
Published: (2023-08-01)

Is Hepatocellular Carcinoma in Fatty Liver Different to Non-Fatty Liver?
by: Xuan-vinh Kevin Nguyen, et al.
Published: (2022-09-01)

Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
by: Karim Seif El Dahan, et al.
Published: (2023-02-01)

Ginsenoside Rb1 ameliorates liver fat accumulation by upregulating perilipin expression in adipose tissue of db/db obese mice
by: Xizhong Yu, et al.
Published: (2015-07-01)

Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review
by: Aitor Odriozola, et al.
Published: (2023-04-01)

Perilipin-5 as a potential new biomarker in patients with liver disease and impaired De Ritis ratio
by: Ceyhan Hacıoğlu, et al.
Published: (2021-12-01)

Challenges and Solutions in the Management of Hepatocellular Carcinoma Associated with Non-Alcoholic Fatty Liver Disease
by: Ramona Cadar, et al.
Published: (2023-09-01)

Ruptured hepatocellular carcinoma and non-alcoholic fatty liver disease, a potentially life-threatening complication in a population at increased risk
by: Carlos M. Nuño-Guzmán, et al.
Published: (2020-01-01)

Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease
by: Diwakar Suresh, et al.
Published: (2020-11-01)

Fatty acid binding protein-4 promotes alcohol-dependent hepatosteatosis and hepatocellular carcinoma progression
by: Neha Attal, et al.
Published: (2021-01-01)

Non-alcoholic fatty liver disease-related hepatocellular carcinoma
by: Darine Daher, et al.
Published: (2023-03-01)

Neutrophil‐lymphocyte ratio in relation to risk of hepatocellular carcinoma in patients with non‐alcoholic fatty liver disease
by: Claire E. Thomas, et al.
Published: (2023-02-01)

Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
by: Ji-Won Park, et al.
Published: (2021-12-01)

The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
by: Teodora Biciusca, et al.
Published: (2023-10-01)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
by: Daryl Ramai, et al.
Published: (2021-12-01)

Perilipin-related protein regulates lipid metabolism in C. elegans
by: Ahmed Ali Chughtai, et al.
Published: (2015-09-01)

Perilipins: a diversity of intracellular lipid droplet proteins
by: Hiroyuki Itabe, et al.
Published: (2017-04-01)

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
by: Cheng-Wei Yu, et al.
Published: (2023-12-01)

Perilipin 5 and Lipocalin 2 Expression in Hepatocellular Carcinoma
by: Anastasia Asimakopoulou, et al.
Published: (2019-03-01)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey
by: Helma P. Cotrim, et al.
Published: (2016-05-01)

Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound Elastography
by: Monica Lupsor-Platon, et al.
Published: (2020-09-01)

Proteomics and metabolic phenotyping define principal roles for the aryl hydrocarbon receptor in mouse liver
by: Jian Jin, et al.
Published: (2021-12-01)

Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
by: Jae Seung Lee, et al.
Published: (2021-09-01)

Perilipin 5 S155 phosphorylation by PKA is required for the control of hepatic lipid metabolism and glycemic control
by: Stacey N. Keenan, et al.
Published: (2021-01-01)

Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease
by: Carlo Smirne, et al.
Published: (2020-11-01)

The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
by: Aleksandra Hliwa, et al.
Published: (2021-06-01)

Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020-06-01)

Role of Doppler ultrasonography of the splenoportal system in diagnosing early hepatic dysfunction in non-alcoholic fatty liver disease patients
by: Safeeq Ahmed Meeran S, et al.
Published: (2023-10-01)

Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine
by: Elena Grasselli, et al.
Published: (2017-09-01)

Non-alcoholic Fatty Liver Disease Affect Efficacy of Immune Checkpoint Inhibitors for Patients with Hepatocellular Carcinoma: Manifestations and Mechanisms
by: YUAN Ye, et al.
Published: (2022-11-01)